TriSalus Life Sciences (TLSI) Stock Chart & Stock Price History $4.26 -0.16 (-3.51%) As of 12:51 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock TriSalus Life Sciences Stock Price Performance The TriSalus Life Sciences (TLSI) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 0.59%, with a year-to-date return of -14.87%. In the past month, the stock has decreased 9.83%, reflecting recent market activity. As of the latest close, TriSalus Life Sciences traded at $4.42 with a market cap of $220.41 million and volume of 263,706 shares. Receive TLSI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for TriSalus Life Sciences and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-7.68%1 Month Performance-9.83%3 Month Performance-14.70%Year-To-Date Performance-14.87%1 Year Performance+0.59% TLSI Stock Chart for Friday, October, 10, 2025 TLSI Chart by TradingView TriSalus Life Sciences Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/09/2025$4.85$4.42-8.87%$4.85$4.35263,706 shs$220.41 million10/08/2025$4.78$4.85+1.46%$4.85$4.56189,127 shs$241.87 million10/07/2025$4.63$4.78+3.24%$4.80$4.57181,419 shs$238.38 million10/06/2025$4.62$4.63+0.22%$4.66$4.4955,718 shs$230.88 million10/03/2025$4.52$4.62+2.21%$4.70$4.4395,649 shs$230.39 million10/02/2025$4.56$4.52-0.88%$4.60$4.4253,636 shs$225.41 million10/01/2025$4.65$4.56-1.94%$4.79$4.5553,755 shs$227.41 million09/30/2025$4.67$4.65-0.43%$4.70$4.5860,432 shs$231.88 million09/29/2025$4.70$4.67-0.64%$4.72$4.1352,543 shs$232.89 million09/26/2025$4.76$4.70-1.26%$4.75$4.6227,748 shs$234.39 million Get the Latest News and Ratings for TLSI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for TriSalus Life Sciences and its competitors with MarketBeat's FREE daily newsletter. 09/25/2025$4.84$4.76-1.65%$4.89$4.7139,551 shs$237.38 million09/24/2025$4.87$4.84-0.62%$5.00$4.7682,404 shs$241.36 million09/23/2025$4.88$4.87-0.20%$4.97$4.76152,024 shs$242.87 million09/22/2025$4.90$4.88-0.41%$4.99$4.71138,504 shs$243.37 million09/19/2025$4.92$4.90-0.41%$5.04$4.80871,167 shs$244.36 million09/18/2025$4.80$4.92+2.50%$5.04$4.71134,551 shs$245.35 million09/17/2025$4.73$4.80+1.48%$4.83$4.65124,475 shs$239.38 million09/16/2025$4.60$4.73+2.83%$4.77$4.5076,013 shs$235.89 million09/15/2025$4.43$4.60+3.84%$4.93$4.4251,839 shs$229.39 million09/12/2025$4.68$4.43-5.34%$4.72$4.41117,301 shs$220.92 million09/11/2025$4.73$4.68-1.06%$4.80$4.5975,028 shs$233.39 million09/10/2025$4.90$4.73-3.47%$4.92$4.7177,687 shs$235.89 million09/09/2025$5.01$4.90-2.20%$5.10$4.81102,526 shs$244.36 million Related Companies iRadimed Stock Chart Beta Bionics Stock Chart Embecta Stock Chart Tandem Diabetes Care Stock Chart AxoGen Stock Chart SiBone Stock Chart ClearPoint Neuro Stock Chart Bioventus Stock Chart Avanos Medical Stock Chart ZimVie Stock Chart Receive TLSI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for TriSalus Life Sciences and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TLSI) was last updated on 10/10/2025 by MarketBeat.com Staff From Our PartnersBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredThe 7 Warning Signals Flashing Red Right NowA free report revealing the 7 key indicators that have predicted every major economic collapse since 1929. ...American Alternative | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredThe best AI stock you aren’t watching (but Elon is)Elon Musk's AI empire is already being built... not in the spotlight, but in the background. One public cou...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TriSalus Life Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TriSalus Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
